Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
NuVasive Inc. said today that it promoted its interim chief executive to the full-time spot, naming chairman Gregory Lucier CEO.
NuVasive, which in April ousted longtime chairman & CEO Alex Lukianov over violations of its internal expense account and personnel policies, had named Lucier interim CEO and chairman while it sought a replacement – who turned out to be Lucier. Read more
Royal Philips said it will work with a major hospital in the Netherlands on a new diagnostic imaging approach for spotting and treating restricted blood flow in feet due to diabetes.
Philips said it will team with Academic Medical Center in Amsterdam to test the technique as part of a European multi-center study. They want to develop technology that analyzes perfusion angiography images and also produces quantitative information on blood flow in the capillaries of the foot. Read more
The outlook for ablation and cardiac rhythm management technologies is looking up, according to Leerink Partners analyst Danielle Antalffy, writing after reviewing the latest offerings from medical device companies at the annual Heart Rhythm Society meeting in Boston recently.
“Our extensive checks with both companies and physicians lead us to believe that current market growth rates – basically flat to up slightly on an organic basis for CRM and strong double-digits for AF ablation – are sustainable for the foreseeable future in large part driven by ongoing innovation among all major players,” Antalffy wrote in a note to investors. Read more